Aclaris Therapeutics (ACRS) Stock Price & Financial Analysis
Aclaris Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Aclaris Therapeutics
What is the current stock price for ACRS?
As of the latest trading session, ACRS stock trades at $4.50. The 52-week range is $1.34–$5.15, with a day range of $4.37–$4.58.
What is the P/E ratio for ACRS?
The P/E ratio (Price-to-Earnings) for ACRS is shown in the Key Statistics section. This valuation metric helps compare Aclaris Therapeutics, Inc. to industry peers.
Does ACRS pay dividends?
Aclaris Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ACRS?
Based on 8 analysts, the consensus for ACRS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ACRS?
Aclaris Therapeutics's market capitalization is $579.6M, classifying it as a small-cap company. Aclaris Therapeutics operates in the Healthcare sector within the Biotechnology industry.